Myriam Villafana Suarez, MD
Gastroenterology · San Juan, PRNPI 1346234358
Payments from drug & device makers
Across 67 payments — averaging $30.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Gilead$207
- E.r. Squibb & Sons, L.L.C.$176
- Johnson & Johnson$124
- Intercept Pharmaceuticals, Inc.$67
- Ferring Pharmaceuticals Inc.$63
- plus $123 from 4 others
What the payments were for
- Consulting fees$432%
- Food & beverage$1,89693%
- Education$1085%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 34 | $1,286 |
| Gilead | 13 | $207 |
| E.r. Squibb & Sons, L.L.C. | 5 | $176 |
| Johnson & Johnson(2 entities) | 2 | $124 |
| Intercept Pharmaceuticals, Inc. | 3 | $67 |
| Ferring Pharmaceuticals Inc. | 4 | $63 |
| Madrigal Pharmaceuticals | 2 | $40 |
| Amgen | 2 | $40 |
| Exact Sciences | 1 | $25 |
| PBG Puerto Rico LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,047 in reported general payments places this provider in the 50th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexlansoprazole DrDexlansoprazole | 50 | $10,299 |
| DexilantDexlansoprazole | 14 | $8,825 |
| Pantoprazole Sodium | 463 | $4,455 |
| Rabeprazole Sodium | 31 | $2,704 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 58 | $2,351 |
| Sucralfate | 15 | $1,894 |
| Hydrocortisone | 20 | $581 |
| Procto-Med HcHydrocortisone | 15 | $371 |
| Famotidine | 41 | $371 |
| Gabapentin | 12 | $250 |
| Meperidine HclMeperidine Hcl/Pf | 13 | $63 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in San Juan
- Marcia Cruz CorreaSan Juan$12.4M
- Jose Rivera-AcostaSan Juan$882K
- Esther TorresSan Juan$493K
- Melvyn AcostaSan Juan$358K
- Melvin Melendez RiosSan Juan$129K
- Loscar SantiagoSan Juan$65K
- Henry Gonzalez RiveraSan Juan$34K
- Jose Munoz AcabaSan Juan$28K
- Hector LozanoSan Juan$28K
- Doris ToroSan Juan$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.